Cerivastatin Lactone (CAS 158878-47-8)
See product citations (1)
QUICK LINKS
Cerivastatin Lactone represents a lactone form of cerivastatin, a synthetic lipophilic statin. In research applications, this compound is particularly valuable for studying the biochemical and mechanistic pathways of statin lactonization, a process that affects statin metabolism. The transformation of cerivastatin to its lactone form is of keen interest, as it offers insights into the aspects of statins, where the lactone form can be considered an inactive precursor that undergoes enzymatic hydrolysis to yield the active acid form. Through investigations using Cerivastatin Lactone, researchers can explore the kinetics of lactonization and hydrolysis, elucidating the metabolic fate of statins and guiding the development of new compounds with optimized profiles. This research has profound implications for the design of safer and more effective statins by enhancing our comprehension of their metabolic pathways.
Cerivastatin Lactone (CAS 158878-47-8) References
- Quantitation of cerivastatin and its seven acid and lactone biotransformation products in human serum by liquid chromatography-electrospray tandem mass spectrometry. | Jemal, M., et al. 1999. J Chromatogr B Biomed Sci Appl. 736: 19-41. PMID: 10676982
- A comparison of the effects of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro. | Ishigami, M., et al. 2001. Drug Metab Dispos. 29: 282-8. PMID: 11181496
- Safety of statins (hydroxymethyl glutaryl coenzyme a reductase inhibitors): different mechanisms of metabolism and drug transport may have clinical relevance. | Vormfelde, SV. 2001. Arch Intern Med. 161: 1012-3. PMID: 11295969
- Personnel-to-patient transmission of hepatitis C virus: underestimation of exposure. | Rieger, MA., et al. 2001. Arch Intern Med. 161: 1017-8. PMID: 11295980
- Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes. | Wang, JS., et al. 2002. Drug Metab Dispos. 30: 1352-6. PMID: 12433802
- Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors. | Fujino, H., et al. 2004. Xenobiotica. 34: 961-71. PMID: 15801541
- (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential. | Ahmad, S., et al. 2008. J Med Chem. 51: 2722-33. PMID: 18412317
- Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis. | Kaspera, R., et al. 2010. Pharmacogenet Genomics. 20: 619-29. PMID: 20739906
- Safety of statins. | Maji, D., et al. 2013. Indian J Endocrinol Metab. 17: 636-46. PMID: 23961479
- Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition. | Schirris, TJ., et al. 2015. Cell Metab. 22: 399-407. PMID: 26331605
- Statin Lactonization by Uridine 5'-Diphospho-glucuronosyltransferases (UGTs). | Schirris, TJ., et al. 2015. Mol Pharm. 12: 4048-55. PMID: 26412035
- Quantitation of Teriflunomide in Human Serum/Plasma Across a 40,000-Fold Concentration Range by LC/MS/MS. | Rule, GS., et al. 2016. Methods Mol Biol. 1383: 195-203. PMID: 26660188
- Cerivastatin Nanoliposome as a Potential Disease Modifying Approach for the Treatment of Pulmonary Arterial Hypertension. | Lee, Y., et al. 2018. J Pharmacol Exp Ther. 366: 66-74. PMID: 29695410
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Cerivastatin Lactone, 2.5 mg | sc-204679 | 2.5 mg | $318.00 |